CAS NO: | 2375240-92-7 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Efruxifermin is anFc-FGF21fusion protein (humanIgG1Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis[1]. | ||||||||
IC50& Target |
| ||||||||
体内研究 (In Vivo) | Efruxifermin (0-100 mg/kg,皮下注射,每周一次,持续4或26周)以剂量依赖的方式减少 Sprague Dawley 大鼠的体重增加[1]。
| ||||||||
CAS 号 | 2375240-92-7 | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |